Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in TaxesChange in TaxesChange in Working CapitalChange in Working CapitalDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Koninklijke Philips (PHG) Change in Cash (2009 - 2013)

Koninklijke Philips' quarterly Change in Cash came in at -$1.8 billion in Q2 2013, down 42.39% year-on-year from -$3.2 billion in Q2 2012, and down 42.39% quarter-over-quarter from -$1.3 billion in Q2 2012.

Koninklijke Philips has reported Change in Cash for 5 years, with the latest figure at -$1.8 billion in Q2 2013.

  • For the quarter ending Q2 2013, Change in Cash fell 42.39% year-over-year to -$1.8 billion; the trailing twelve-month figure through Jun 2013 stood at -$8.0 billion (down 12.2% YoY), and the FY2025 full-year result was $630.9 million, up 18.08% from the prior year.
  • Change in Cash for Q2 2013 stood at -$1.8 billion, down from -$1.3 billion in the prior quarter.
  • The five-year high for Change in Cash was $1.9 billion in Q4 2010, with the low at -$3.1 billion in Q2 2011.
  • Average Change in Cash over 5 years is -$648.3 million, with a median of -$508.8 million recorded in 2011.
  • Year-over-year, Change in Cash soared 320.68% in 2010 and plunged 7929.44% in 2011.
  • Tracing PHG's Change in Cash over 5 years: stood at $454.8 million in 2009, then soared by 320.68% to $1.9 billion in 2010, then slumped by 195.3% to -$1.8 billion in 2011, then increased by 29.74% to -$1.3 billion in 2012, then plunged by 42.39% to -$1.8 billion in 2013.
  • The last three Change in Cash figures came in at -$1.8 billion (Q2 2013), -$1.3 billion (Q2 2012), and -$1.8 billion (Q4 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.72 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -1.13 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -136.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -504.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -492.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.23 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.90 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -167.70 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2013 -1.82 Bn
Jun 30, 2012 -1.28 Bn
Dec 31, 2011 -1.82 Bn
Jun 30, 2011 -3.09 Bn
Mar 31, 2011 -951.78 Mn
Dec 31, 2010 1.91 Bn
Sep 30, 2010 -65.85 Mn
Jun 30, 2010 39.52 Mn
Mar 31, 2010 149.55 Mn
Dec 31, 2009 454.83 Mn